Toronto, Ontario–(Newsfile Corp. – November 24, 2025) – ONGold Resources Ltd. (TSXV: ONAU) (OTCQB: ONGRF) (the “Company” or “ONGold“) is pleased to announce that it has acquired, by staking, additional claims surrounding the Ti-pa-haa-kaa-ning (“TPK“) project in northwestern Ontario. ONGold has added 73 multi-cell and single cell claims covering approximately 21,969 hectares (1,118 cells). The TPK property […]
Toronto, Ontario–(Newsfile Corp. – November 24, 2025) – Parkit Enterprise Inc. (TSXV: PKT) (“Parkit” or the “Company”), is pleased to announce that it has contributed the 3.55 acres of lands at 568 Second Street, London, Ontario, to a three-party joint venture called 760 Second Street Partnership (the “Joint Venture“) for total contribution of $12,900,000, subject to
The global energy transition is being driven by companies building the infrastructure, technologies, and fuel systems needed to decarbonize heavy industry, transport, and power generation. Large-cap leaders have already established dominant positions in hydrogen production, fuel cell systems, renewable power, and grid-scale storage. At the same time, a new class of innovators is emerging with
WOBURN, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) — Vertero Therapeutics, a clinical-stage biotechnology company breaking barriers in neurodegenerative disease treatment, today announced that it has initiated a Phase 1 study of its lead candidate, VT-5006, a first-in-class, gut-selective small molecule for the treatment of Parkinson's disease (PD). VT-5006 is a novel, oral therapeutic developed by
NEW YORK, NY / ACCESS Newswire / November 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Agios Pharmaceuticals, Inc. ("Agios Pharmaceuticals, Inc.") (NASDAQ:AGIO) concerning possible violations of federal securities laws. On November 19, 2025, Agios reported topline results from its RISE UP Phase 3 trial of Mitapivat in
Vertero Initiates Phase 1 Study of VT-5006, A Selective Small Molecule Therapy for Parkinson's Disease VT-5006 is a first-in-class small molecule designed to precisely engage a validated peripheral target to delay onset and slow progression of Parkinson's disease GlobeNewswire November 24, 2025 WOBURN, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) — Vertero Therapeutics, a clinical-stage biotechnology
BTQ Technologies Corp.(“BTQ” or the “Company”) (Nasdaq: BTQ) (CBOE CA: BTQ) (FSE: NG3), a global quantum technology company focused on securing mission-critical networks, is pleased to announce its inclusion in the MSCI Canada Small Cap Index, effective as of November 25, 2025, following the October index review by MSCI Inc. https://mma.prnewswire.com/media/2830618/BTQ_Technologies_Corp__BTQ_Technologies_Added_to_MSCI_Canada_Sma.jpg The MSCI Canada Small
ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTC: BABYD) (FSE: 0YL)(the “Company”) announces that the Company has entered into a new convertible security funding agreement (the “Agreement”) with Lind Global Fund III LP,an entity managed by The Lind Partners, LLC, a New York-based institutional fund manager (together, “Lind”). Under the terms of the Agreement, the Company
Defense Metals Corp. (“Defense Metals” or the “Company”) (TSXV: DEFN) (OTCQB: DFMTF) (FSE: 35D), a company focused on the development of the Wicheeda Rare Earth Project (Wicheeda Project), located near Prince George, British Columbia, Canada, is pleased to recognize the continued support of the Government of Canada and theMcLeod Lake Indian Band (MLIB) in the
Hot Chili Limited (ASX: HCH) (TSXV: HCH) (OTCQX: HHLKF) (“Hot Chili” or “Company”) advises that the Annual General Meeting will be held on Thursday, 27 November 2025 at 9:30am AWST and can be attended either in person or online in real-time. A live webcast of the AGM will be available to all shareholders through the